Peter Rouvelas, MD
Interventional Cardiology · Brooklyn, NYNPI 1245243609
Payments from drug & device makers
Across 438 payments — averaging $758.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$207K
- Johnson & Johnson$86K
- Amarin Pharma, Inc.$27K
- Edwards Lifesciences$7K
- Abbott$1K
- Amgen$524
- plus $3K from 17 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 126 | $206,648 |
| Johnson & Johnson | 104 | $86,419 |
| Amarin Pharma, Inc. | 36 | $27,008 |
| Edwards Lifesciences | 13 | $7,484 |
| Abbott | 14 | $1,443 |
| Amgen(2 entities) | 21 | $524 |
| Sanofi-aventis U.S. LLC | 21 | $487 |
| Novartis | 21 | $396 |
| AstraZeneca | 17 | $392 |
| GSK | 17 | $373 |
| Alnylam Pharmaceuticals Inc. | 9 | $235 |
| Pfizer | 8 | $171 |
| Actelion Pharmaceuticals US, Inc. | 7 | $164 |
| Boehringer Ingelheim | 6 | $160 |
| Merck | 5 | $114 |
| Boston Scientific | 3 | $84 |
| Biotronik Inc. | 2 | $48 |
| Lilly USA, LLC | 3 | $47 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $24 |
| Corcept Therapeutics | 1 | $22 |
| Astellas Pharma US Inc | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
How this compares
$332,291 in reported general payments places this provider in the 85th percentile of 382 interventional cardiology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Brooklyn
- Jamie MengBrooklyn$1.8M
- Yuhei KobayashiBrooklyn$246K
- Martin LeonNew York$13.5M
- David CohenRoslyn$9.8M
- Susheel KodaliNew York$6M
- Mohamed Azeem LatibBronx$4.6M
- Richard ShlofmitzRoslyn$4.5M
- Deepak BhattNew York$4.1M
- Samin SharmaNew York$3.7M
- Annapoorna KiniNew York$3.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.